• Home
  • Team
  • Our Approach
  • Careers
  • News
  • Condensates.com

Press releases and
Dewpoint in the news

  • Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy

    January 6, 2021

    Dewpoint

  • Dewpoint Appoints Kara Carter, Ph.D., Senior Vice President of Discovery Biology

    December 9, 2020

    Dewpoint

  • Human Frontier Science Program Recognizes Dewpoint Founder Tony Hyman for His Pioneering Work on Biomolecular Condensates

    November 5, 2020

    Human Frontier Science Program

  • Dewpoint Therapeutics Appoints Ameet Nathwani as Chief Executive Officer

    October 13, 2020

    Dewpoint

  • New York Times interviews Rick Young and Amy Gladfelter on the role of condensate “droplets” in COVID-19

    October 9, 2020

    New York Times

  • Dewpoint Therapeutics raises $77 million to go after ‘undruggable’ diseases

    September 29, 2020

    Boston Globe

  • Hooked by the science, Arie Belldegrun joins a group of influentials who believe Dewpoint may have the key to the next big thing in biotech

    September 29, 2020

    Endpoint News

  • Dewpoint Therapeutics to put ‘pedal to the metal’ with $77M round

    September 29, 2020

    FierceBiotech

  • Dewpoint Therapeutics Raises $77M Series B Financing to Advance the Development of Drugs That Target Biomolecular Condensates

    September 29, 2020

    Dewpoint

  • 21 biotech startups that are set to take off, according to top VCs

    August 13, 2020

    Business Insider

1 2 3 … 5 Older

Dewpoint™

  • Our Company
    • Team
    • Our Approach
    • Careers We’re hiring!
    • News
    • Phase Separation
    • Contact Us
  • Condensates.com
    • Publications
    • Event
    • Jobs
    • Resources
    • About
    • Phase Separation, LLPS
Contact Us

Dewpoint Therapeutics
6 Tide Street, Suite 300
Boston, MA 02210
info@dewpointx.com

© 2019–2021 Dewpoint Therapeutics

  • Privacy
  • Terms